Caris Life Sciences and ConcertAI Expand Partnership to Create First-in-Class, Prospectively Matched Clinico-Genomic Research Platform

Contemporaneously Combining Comprehensive Molecular Profiling at Unprecedented Scale with Reference-standard Clinical Data Creates a Novel Platform to Advance Precision Oncology Research IRVING, Texas and CAMBRIDGE, Mass., June 1, 2023  /PRNewswire/ –Caris Life Sciences®(Caris), the leading molecular science, artificial intelligence (AI) and machine learning technology company actively developing and delivering innovative solutions to revolutionize healthcare, and … Read more

ConcertAI’s TeraRecon adds Prostate Cancer Detection/Diagnosis into Eureka Clinical AI Platform with Bot Image, Inc. Partnership

CAMBRIDGE, Mass., May 26, 2023 /PRNewswire/ — The Eureka Clinical AI platform, from ConcertAI’s TeraRecon, the advanced visualization and clinical AI SaaS category leader, now provides clinicians with the state-of-the-art clinical artificial intelligence and deep learning technology necessary to bring fast and accurate prostate cancer detection and diagnosis using bpMRI and AI in partnership with Bot Image, … Read more